GAMMA Investing’s C4 Therapeutics CCCC Stock Holding History

GAMMA Investing’s Portfolio CCCC Stock Details CCCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.76K	Buy	+829	New	+$3.09K	﹤0.01%	3863
2024 Q4	–	Sell	-217	Closed	-$1.24K	–	3787
2024 Q3	$1.24K	Buy	+217	New	+$1.31K	﹤0.01%	3201

Other funds holding CCCC

CAM

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

GAMMA Investing's CCCC Position: Q3 2026 in Review

GAMMA Investing opened a new position in C4 Therapeutics (CCCC) in Q3 2026: 829 shares worth $2.76K. The stake represents ﹤0.01% of the portfolio and ranks #3863 among its holdings. This is a return to the name: GAMMA Investing previously reported a position in CCCC as recently as Q3 2024.

GAMMA Investing first reported a position in CCCC in Q3 2024 and has held it in 2 quarters since. 2 funds tracked by Wall St. Rank hold CCCC as of Q3 2026.

GAMMA Investing held 829 shares of C4 Therapeutics worth $2.76K as of Q3 2026.
C4 Therapeutics was a new GAMMA Investing position in Q3 2026.
C4 Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3863 holding.
GAMMA Investing first reported a position in C4 Therapeutics in Q3 2024 and has held it in 2 quarters since.
2 funds tracked by Wall St. Rank held C4 Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.